Fidson Aims For Global Recognition, Targets WHO Prequalification By 2025

Fidson Aims For Global Recognition, Targets WHO Prequalification By 2025

Fidson Aims For Global Recognition, Targets WHO Prequalification By 2025 …C0NTINUE READING HERE >>>

 

Fidson Healthcare Plc, one of Nigeria’s leading pharmaceutical companies, has set an ambitious goal to achieve World Health Organization (WHO) prequalification by 2025.

This is even as it has announced its partnership with Liddie BE Ltd, a renowned clinical research organisation, to conduct a Bioequivalence (BE) study on its chewable formulation of Albendazole tablets.

Albendazole is an FDA approved medication for the treatment of a variety of parasitic worm infections prevalent in…

>

Be the first to comment

Leave a Reply

Your email address will not be published.


*